Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Obinutuzumab> ?p ?o }
- Obinutuzumab abstract "Obinutuzumab (called afutuzumab until 2009, originally GA101) is a humanized monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer treatment. It was approved under the trade name Gazyva by the US FDA in 2013, and as Gazyvaro by the EMA in Europe, for the treatment of chronic lymphocytic leukemia in combination with chemotherapy in treatment-naive patients.".
- Obinutuzumab atcPrefix "L01".
- Obinutuzumab atcSuffix "XC15".
- Obinutuzumab casNumber "949142-50-1".
- Obinutuzumab fdaUniiCode "O43472U9X8".
- Obinutuzumab wikiPageID "19841411".
- Obinutuzumab wikiPageLength "9158".
- Obinutuzumab wikiPageOutDegree "44".
- Obinutuzumab wikiPageRevisionID "708374229".
- Obinutuzumab wikiPageWikiLink Adaptive_immune_system.
- Obinutuzumab wikiPageWikiLink Afucosylated_monoclonal_antibodies.
- Obinutuzumab wikiPageWikiLink Apoptosis.
- Obinutuzumab wikiPageWikiLink B-cell_chronic_lymphocytic_leukemia.
- Obinutuzumab wikiPageWikiLink B_cell.
- Obinutuzumab wikiPageWikiLink Biogen.
- Obinutuzumab wikiPageWikiLink Breakthrough_therapy.
- Obinutuzumab wikiPageWikiLink CD20.
- Obinutuzumab wikiPageWikiLink CHOP.
- Obinutuzumab wikiPageWikiLink Canadian_Agency_for_Drugs_and_Technologies_in_Health.
- Obinutuzumab wikiPageWikiLink Category:Breakthrough_therapy.
- Obinutuzumab wikiPageWikiLink Category:Hoffmann-La_Roche.
- Obinutuzumab wikiPageWikiLink Chemotherapy.
- Obinutuzumab wikiPageWikiLink Chlorambucil.
- Obinutuzumab wikiPageWikiLink Complement_system.
- Obinutuzumab wikiPageWikiLink Diffuse_large_B-cell_lymphoma.
- Obinutuzumab wikiPageWikiLink ETH_Zurich.
- Obinutuzumab wikiPageWikiLink Epitope.
- Obinutuzumab wikiPageWikiLink Food_and_Drug_Administration.
- Obinutuzumab wikiPageWikiLink Genetic_engineering.
- Obinutuzumab wikiPageWikiLink Glycosylation.
- Obinutuzumab wikiPageWikiLink Hoffmann-La_Roche.
- Obinutuzumab wikiPageWikiLink Humanized_antibody.
- Obinutuzumab wikiPageWikiLink Industrial_fermentation.
- Obinutuzumab wikiPageWikiLink Intravenous_therapy.
- Obinutuzumab wikiPageWikiLink MGAT3.
- Obinutuzumab wikiPageWikiLink Mannosidase.
- Obinutuzumab wikiPageWikiLink Monoclonal_antibody.
- Obinutuzumab wikiPageWikiLink NHS_England.
- Obinutuzumab wikiPageWikiLink National_Institute_for_Health_and_Care_Excellence.
- Obinutuzumab wikiPageWikiLink Natural_killer_cell.
- Obinutuzumab wikiPageWikiLink Non-Hodgkin_lymphoma.
- Obinutuzumab wikiPageWikiLink Primary_biliary_cirrhosis.
- Obinutuzumab wikiPageWikiLink Progressive_multifocal_leukoencephalopathy.
- Obinutuzumab wikiPageWikiLink Rituximab.
- Obinutuzumab wikiPageWikiLink Thrombocytopenia.
- Obinutuzumab wikiPageWikiLinkText "Gazyva".
- Obinutuzumab wikiPageWikiLinkText "Obinutuzumab".
- Obinutuzumab wikiPageWikiLinkText "obinutuzumab".
- Obinutuzumab atcPrefix "L01".
- Obinutuzumab atcSuffix "XC15".
- Obinutuzumab c "6512".
- Obinutuzumab casNumber "949142".
- Obinutuzumab chemspiderid "none".
- Obinutuzumab eliminationHalfLife "2453760.0".
- Obinutuzumab h "10060".
- Obinutuzumab kegg "D09321".
- Obinutuzumab legalUs "Rx-only".
- Obinutuzumab mabType "mab".
- Obinutuzumab molecularWeight "146.1".
- Obinutuzumab n "1712".
- Obinutuzumab o "2020".
- Obinutuzumab routesOfAdministration Intravenous_therapy.
- Obinutuzumab s "44".
- Obinutuzumab source "zu/o".
- Obinutuzumab target CD20.
- Obinutuzumab tradename "Gazyva , Gazyvaro".
- Obinutuzumab type "mab".
- Obinutuzumab unii "O43472U9X8".
- Obinutuzumab verifiedfields "changed".
- Obinutuzumab verifiedrevid "477243496".
- Obinutuzumab wikiPageUsesTemplate Template:Cascite.
- Obinutuzumab wikiPageUsesTemplate Template:Chemspidercite.
- Obinutuzumab wikiPageUsesTemplate Template:Drugbankcite.
- Obinutuzumab wikiPageUsesTemplate Template:Drugbox.
- Obinutuzumab wikiPageUsesTemplate Template:Fdacite.
- Obinutuzumab wikiPageUsesTemplate Template:Immunosuppressants.
- Obinutuzumab wikiPageUsesTemplate Template:Keggcite.
- Obinutuzumab wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Obinutuzumab wikiPageUsesTemplate Template:Reflist.
- Obinutuzumab subject Category:Breakthrough_therapy.
- Obinutuzumab subject Category:Hoffmann-La_Roche.
- Obinutuzumab hypernym Antibody.
- Obinutuzumab type ChemicalSubstance.
- Obinutuzumab type Company.
- Obinutuzumab type Drug.
- Obinutuzumab type Antibody.
- Obinutuzumab type Chemical.
- Obinutuzumab type Company.
- Obinutuzumab type Drug.
- Obinutuzumab type ChemicalObject.
- Obinutuzumab type Thing.
- Obinutuzumab type Q8386.
- Obinutuzumab comment "Obinutuzumab (called afutuzumab until 2009, originally GA101) is a humanized monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer treatment. It was approved under the trade name Gazyva by the US FDA in 2013, and as Gazyvaro by the EMA in Europe, for the treatment of chronic lymphocytic leukemia in combination with chemotherapy in treatment-naive patients.".
- Obinutuzumab label "Obinutuzumab".
- Obinutuzumab sameAs Q389496.
- Obinutuzumab sameAs أوبينوتوزوماب.
- Obinutuzumab sameAs Obinutuzumab.
- Obinutuzumab sameAs Afutuzumab.
- Obinutuzumab sameAs Obinutuzumabas.
- Obinutuzumab sameAs m.04q2lbw.